(Address
of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (925) 223-6700
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.07.
Submission of Matters to a Vote of Security Holders
On
June 4, 2015, Natus Medical Incorporated (the “Company”) held its annual meeting of stockholders. At this meeting, William M. Moore and Doris E. Engibous were re-elected to serve on the Board of Directors for a three-year term until 2018. Additionally, shareholders ratified the appointment of KPMG as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015, provided advisory approval of the Company’s named executive officer compensation, and approved the Company’s Cash Incentive Program.
Proposal
1: Election of Directors
Nominee
For
Against
Abstain
Broker
Non-Votes
Doris
E. Engibous
26,204,741
1,476,394
47,957
3,068,733
William M. Moore
18,532,871
9,148,287
47,934
3,068,733
Proposal
2: Ratification of KPMG as Auditors
For
Against
Abstain
29,994,497
16,377
786,951
Proposal
3: Advisory Approval of the Company’s Executive Compensation
For
Against
Abstain
Broker
Non-Votes
26,037,144
1,403,526
288,422
3,068,733
Proposal
4: Approval of the Company’s Cash Incentive Plan
For
Against
Abstain
Broker
Non-Votes
18,858,966
8,592,265
277,861
3,068,733
No
other matters were considered or voted upon at the meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.